Masamune A, Kikuta K, Hamada S, et al. Nationwide epidemiological survey of autoimmune pancreatitis in Japan in 2016. J Gastroenterol. 2020;55:462–70.

Article  PubMed  Google Scholar 

Shimosegawa T, Chari ST, Frulloni L, et al. International consensus diagnostic criteria for autoimmune pancreatitis: guidelines of the international association of pancreatology. Pancreas. 2011;40:352–8.

Article  PubMed  Google Scholar 

Kawaguchi K, Koike M, Tsuruta K, et al. Lymphoplasmacytic sclerosing pancreatitis with cholangitis: a variant of primary sclerosing cholangitis extensively involving pancreas. Hum Pathol. 1991;22:387–95.

Article  CAS  PubMed  Google Scholar 

Uchida K, Okazaki K. Clinical and pathophysiological aspects of type 1 autoimmune pancreatitis. J Gastroenterol. 2018;53:475–83.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kamisawa T, Takuma K, Tabata T, et al. Serum IgG4-negative autoimmune pancreatitis. J Gastroenterol. 2011;46:108–16.

Article  CAS  PubMed  Google Scholar 

Japan Pancreas Society, the Research Committee of Intractable Pancreatic Disease (Principal investigator: Tooru Shimosegawa) provided by the Ministry of Health, Labour and Welfare of Japan. Japanese Guidelines. For management of autoimmune pancreatitis. Suizo. 2013;2013(28):715–84.

Google Scholar 

The Japan Pancreas Society, the Research Committee of Intractable Diseases for IgG4-related disease supported by the Japanese Ministry of Health. Labor and welfare. amendment of the japanese consensus guidelines for autoimmune pancreatitis. Suizo. 2020;35:465–550.

Google Scholar 

Kanno A, Masamune A, Fujishima F, et al. Diagnosis of autoimmune pancreatitis by EUS-guided FNA using a 22-gauge needle: a prospective multicenter study. Gastrointest Endosc. 2016;84:797-804.e1.

Article  PubMed  Google Scholar 

Lans JI, Geenen JE, Johanson JF, et al. Endoscopic therapy in patients with pancreas divisum and acute pancreatitis: a prospective, randomized, controlled clinical trial. Gastrointest Endosc. 1992;38:430–4.

Article  CAS  PubMed  Google Scholar 

Jacob L, Geenen JE, Catalano MF, et al. Clinical presentation and short-term outcome of endoscopic therapy of patients with symptomatic incomplete pancreas divisum. Gastrointest Endosc. 1999;49:53–7.

Article  CAS  PubMed  Google Scholar 

Ertan A. Long-term results after endoscopic pancreatic stent placement without pancreatic papillotomy in acute recurrent pancreatitis due to pancreas divisum. Gastrointest Endosc. 2000;52:9–14.

Article  CAS  PubMed  Google Scholar 

Kamisawa T, Chen PY, Tu Y, et al. Pancreatic cancer with a high serum IgG4 concentration. World J Gastroenterol. 2006;12:6225–8.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Liu Q, Niu Z, Li Y, et al. Immunoglobulin G4 (IgG4)-positive plasma cell infiltration is associated with the clinicopathologic traits and prognosis of pancreatic cancer after curative resection. Cancer Immunol Immunother. 2016;65:931–40.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Nishino T, Oyama H, Toki F, et al. Differentiation between autoimmune pancreatitis and pancreatic carcinoma based on endoscopic retrograde cholangiopancreatography findings. J Gastroenterol. 2010;45:988–96.

Article  PubMed  Google Scholar 

Yamaguchi K, Ohuchida J, Ohtsuka T, et al. Intraductal papillary-mucinous tumor of the pancreas concomitant with ductal carcinoma of the pancreas. Pancreatology. 2002;2:484–90.

Article  PubMed  Google Scholar 

Tada M, Kawabe T, Arizumi M, et al. Pancreatic cancer in patients with pancreatic cystic lesions: a prospective study in 197 patients. Clin Gastroenterol Hepatol. 2006;4:1265–70.

Article  PubMed  Google Scholar 

Uehara H, Nakaizumi A, Ishikawa O, et al. Development of ductal carcinoma of the pancreas during follow-up of branch duct intraductal papillary mucinous neoplasm of the pancreas. Gut. 2008;57:1561–5.

Article  CAS  PubMed  Google Scholar 

Umehara H, Okazaki K, Kawa S, et al. Research program for intractable disease by the ministry of health, labor and welfare MHLW Japan. The 2020 revised comprehensive diagnostic RCD criteria for IgG4-RD. Mod Rheumatol. 2021;31:529–33.

Article  CAS  PubMed  Google Scholar 

Kamisawa T, Shimosegawa T, Okazaki K, et al. Standard steroid treatment for autoimmune pancreatitis. Gut. 2009;58:1504–7.

Article  CAS  PubMed  Google Scholar 

Hart PA, Kamisawa T, Brugge WR, et al. Long-term outcomes of autoimmune pancreatitis: a multicentre, international analysis. Gut. 2013;62:1771–6.

Article  PubMed  Google Scholar 

Moon SH, Kim MH, Park DH, et al. Is a 2-week steroid trial after initial negative investigation for malignancy useful in differentiating autoimmune pancreatitis from pancreatic cancer? Prospect Outcome Stud Gut. 2008;57:1704–12.

CAS  Google Scholar 

Kubota K, Watanabe S, Uchiyama T, et al. Factors predictive of relapse and spontaneous remission of autoimmune pancreatitis patients treated/not treated with corticosteroids. J Gastroenterol. 2011;46:834–42.

Article  CAS  PubMed  Google Scholar